• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Policy

Latest News

White House | Image credit: Maksym Yemelyanov - stock.adobe.com
White House to Announce Second Drug Pricing Deal as AstraZeneca Joins TrumpRx

October 10th 2025

AstraZeneca has struck a deal with the Trump administration to sell lower-priced drugs via TrumpRx, following a similar agreement with Pfizer.

As far as the measures improving patient access to medications, experts are skeptical that Most Favored Nation drug pricing will have its intended effect. | Image credit: retrostar - stock.adobe.com
A "One-Two Punch" to Innovation? The Most Favored Nation Order and Broader US Drug Pricing Reform

October 10th 2025

Hatfield Q&A Thumbnail
Integrating Clinical, Dispensing, and Fiscal Components for Continuity of Care: Chad Hatfield, PharmD, MHA, BCPS

October 9th 2025

Contributor: Why Public Health Keeps Failing—and How to Fix It
Contributor: Why Public Health Keeps Failing—and How to Fix It

October 7th 2025

Amgen | Image Credit: MichaelVi - stock.adobe.com
Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms

October 6th 2025

<1
...
8182838485
© 2025 MJH Life Sciences
AJMC®
All rights reserved.